Velocity Clinical Research

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity2 trials
• Psoriasis1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Completed1 trial

Lead sponsor

• Alumis Inc1 trial
• Currax Pharmaceuticals1 trial
• Regor Pharmaceuticals Inc.1 trial

Running trials

• Active, not recruiting

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· Phase 3· Alumis Inc· Source

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source

Closed trials

• Completed

  Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

  NCT06867718· Phase 2· Regor Pharmaceuticals Inc.· Source